Circle Internet Group, SpringWorks Therapeutics, Blueprint Medicines, Novo Nordisk A/S, and BlackRock are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at an above-average rate compared to the overall market. These firms typically reinvest most of their profits back into research, development or expansion rather than pay out large dividends. Investors in growth stocks seek capital appreciation, betting that accelerating business performance will drive up the share price over time. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Circle Internet Group (CRCL)
Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.
Shares of CRCL traded up $30.89 during midday trading on Wednesday, hitting $180.04. 34,709,469 shares of the company traded hands, compared to its average volume of 34,725,023. The stock has a market cap of $40.07 billion and a PE ratio of -14,227.91. Circle Internet Group has a one year low of $64.00 and a one year high of $184.44.
Read Our Latest Research Report on CRCL
SpringWorks Therapeutics (SWTX)
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.
Shares of SWTX traded down $0.11 during mid-day trading on Wednesday, reaching $46.76. 5,856,007 shares of the stock traded hands, compared to its average volume of 4,113,243. The company has a market cap of $3.52 billion, a price-to-earnings ratio of -13.71 and a beta of 0.70. SpringWorks Therapeutics has a 1 year low of $28.21 and a 1 year high of $62.00. The firm has a fifty day moving average price of $44.48 and a 200 day moving average price of $43.89.
Read Our Latest Research Report on SWTX
Blueprint Medicines (BPMC)
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.
Blueprint Medicines stock traded down $0.19 during midday trading on Wednesday, hitting $128.04. 2,040,816 shares of the company's stock were exchanged, compared to its average volume of 1,909,044. The stock has a 50-day moving average price of $101.93 and a two-hundred day moving average price of $97.48. Blueprint Medicines has a 52-week low of $73.04 and a 52-week high of $128.34. The company has a market cap of $8.27 billion, a P/E ratio of -51.84 and a beta of 0.84. The company has a debt-to-equity ratio of 1.01, a quick ratio of 2.75 and a current ratio of 2.80.
Read Our Latest Research Report on BPMC
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NYSE:NVO traded up $0.17 during trading on Wednesday, reaching $74.51. The company had a trading volume of 3,153,327 shares, compared to its average volume of 7,051,596. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The company has a fifty day moving average of $67.80 and a two-hundred day moving average of $79.21. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15.
Read Our Latest Research Report on NVO
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
NYSE:BLK traded up $15.70 during trading hours on Wednesday, reaching $984.88. The company's stock had a trading volume of 233,140 shares, compared to its average volume of 688,398. The firm has a 50-day simple moving average of $942.61 and a 200-day simple moving average of $971.07. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.34 and a current ratio of 4.34. BlackRock has a 1 year low of $773.74 and a 1 year high of $1,084.22. The firm has a market capitalization of $152.59 billion, a price-to-earnings ratio of 23.93, a PEG ratio of 2.99 and a beta of 1.41.
Read Our Latest Research Report on BLK
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Circle Internet Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Circle Internet Group wasn't on the list.
While Circle Internet Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
